Paper41722201
SELE is associated with reduced breast cancer susceptibility: Evidence from Mendelian randomization and single-cell transcriptome.
Chen H and 4 others. Transl Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. SELE is associated with reduced breast cancer susceptibility: Evidence from Mendelian randomization and single-cell transcriptome. Papers, record 41722201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41722201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SELE is associated with reduced breast cancer susceptibility: Evidence from Mendelian randomization and single-cell transcriptome.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37794186 | Plasma proteomic associations with genetics and health in the UK Biobank. | Nature | 2023 | https://conductscience.org/library/papers/37794186 | PubMed |
| 2 | 21216802 | Using multiple genetic variants as instrumental variables for modifiable risk factors. | Stat Methods Med Res | 2012 | https://conductscience.org/library/papers/21216802 | PubMed |
| 3 | 34560276 | Machine-learning methods for ligand-protein molecular docking. | Drug Discov Today | 2022 | https://conductscience.org/library/papers/34560276 | PubMed |
| 4 | 33950524 | A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. | EMBO J | 2021 | https://conductscience.org/library/papers/33950524 | PubMed |
| 5 | 33565143 | Adhesion to E-selectin primes macrophages for activation through AKT and mTOR. | Immunol Cell Biol | 2021 | https://conductscience.org/library/papers/33565143 | PubMed |
| 6 | 36653562 | FinnGen provides genetic insights from a well-phenotyped isolated population. | Nature | 2023 | https://conductscience.org/library/papers/36653562 | PubMed |
| 7 | 20472501 | Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/20472501 | PubMed |
| 8 | 32424353 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. | Nat Genet | 2020 | https://conductscience.org/library/papers/32424353 | PubMed |
| 9 | 37220626 | A simple new approach to variable selection in regression, with application to genetic fine mapping. | J R Stat Soc Series B Stat Methodol | 2020 | https://conductscience.org/library/papers/37220626 | PubMed |
| 10 | 31268329 | Highly Integrated Nanoplatform Based on an E-Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment. | Mol Pharm | 2019 | https://conductscience.org/library/papers/31268329 | PubMed |
| 11 | 21949812 | Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy. | PLoS One | 2011 | https://conductscience.org/library/papers/21949812 | PubMed |
| 12 | 12013533 | Genetic basis of human breast cancer metastasis. | J Mammary Gland Biol Neoplasia | 2001 | https://conductscience.org/library/papers/12013533 | PubMed |
| 13 | 37379654 | Plasma protein biomarkers for early prediction of lung cancer. | EBioMedicine | 2023 | https://conductscience.org/library/papers/37379654 | PubMed |
| 14 | 23559002 | Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/23559002 | PubMed |
| 15 | 21780194 | E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. | Mol Carcinog | 2012 | https://conductscience.org/library/papers/21780194 | PubMed |
| 16 | 25778910 | Meta-analyses: what is heterogeneity? | BMJ | 2015 | https://conductscience.org/library/papers/25778910 | PubMed |
| 17 | 23401487 | Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination. | J Exp Med | 2013 | https://conductscience.org/library/papers/23401487 | PubMed |
| 18 | 32404014 | PDB-2-PBv3.0: An updated protein block database. | J Bioinform Comput Biol | 2020 | https://conductscience.org/library/papers/32404014 | PubMed |
| 19 | 33151290 | PubChem in 2021: new data content and improved web interfaces. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33151290 | PubMed |
| 20 | 35882941 | Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: a Mendelian randomisation analysis. | Br J Cancer | 2022 | https://conductscience.org/library/papers/35882941 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41722201
GET https://conductscience.org/api/papers/v1/41722201/references?page=2